Representative Equity Offerings

• Informatica's* $841M initial public offering and $408M follow-on offering
• BioAge’s $238M initial public offering and concurrent private placement
• bluebird bio’s* $500M follow-on offering
• Cerulean Pharma’s* $60M initial public offering
• Change Healthcare’s $640.7M initial public offering
• Clementia Pharmaceuticals’* $120M initial public offering and $70.26M follow-on offering
• Dimension Therapeutics’* $71.5M initial public offering
• Habit Restaurants on its $90M initial public offering and $154.8M follow-on offering
• Idera Pharmaceuticals’* $50M initial public offering
• Karyopharm Therapeutics’* $108.8M initial public offering
• Kiniksa Pharmaceuticals’* $152.6M initial public offering
• LogicBio Therapeutics on its $70M initial public offering and $50M follow-on offering
• Madrigal Pharmaceuticals’* $129.42M follow-on offering
• Moderna’s* $604.3M initial public offering and $1.34B follow-on offering
• Momenta Pharmaceuticals’* $225M initial public offering
• nCino’s* $250M initial public offering
• Planet Fitness on its $1.275B securitized financing facility transaction
• Proteostasis Therapeutics’* $50M initial public offering
• Quanterix’s* $64.13M initial public offering and $60M follow-on offering
• Radius Health’s* $300M follow-on offering
• Relay Therapeutics’* $400M initial public offering
• Sarepta Therapeutics on its $350M follow-on offering
• Seres Therapeutics’* $225.75M follow-on offering
• Sixth Street Specialty Lending’s* $86.6M follow-on offering
• Surgery Partners on its $271.2M initial public offering
• TherapeuticsMD’s* $125M follow-on offering

Representative High Yield Bond Offerings

• Karyopharm Therapeutics* on its $150M convertible senior notes offering
• NFP on its $200M debt financing

Representative SPAC Transactions

• Nextdoor in its business combination with Khosla Ventures Acquisition Co. II
• Altimeter Growth on its $450M initial public offering
• Ares Acquisition’s* $870M initial public offering
• Ascendant Digital Acquisition’s* $360M initial public offering
• Carney Technology Acquisition’s* $350M initial public offering
• Fortress Capital Acquisition’s* $350M initial public offering
• Jiya Acquisition’s* $100M initial public offering
• Juniper Industrial Holding’s $300M initial public offering
• Montes Archimedes Acquisition’s* $400M initial public offering
• Reinvent Technology Partners’* $600M initial public offering
• Reinvent Technology Partners 2’s* $200M initial public offering
• Sustainable Development Acquisition I in its $275M initial public offering
• TCW Special Purpose Acquisition’s $450M initial public offering

*Representing the Representatives on behalf of the Underwriters/Initial Purchasers, including such investment banks as Goldman Sachs, Morgan Stanley, J.P. Morgan, Barclays, BofA Securities, Citigroup, Cowen, Credit Suisse, Deutsche Bank and Leerink, among others.